MedTrace Logo

Autonomic Regulation Trial (ART)

NCT00196274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study was to develope and evaluate a new method for risk stratification which predicts high mortality risk in patients with cardiac disease based on simultateous examination of high resolution ECG, continuous arterial pressure and a breathing signal.

Conditions

  • Infarction, Myocardial

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Georg Schmidt, MD · Deutsches Herzzentrum Muenchen

  • Petra Barthel, MD · Deutsches Herzzentrum Muenchen

  • Axel Bauer, MD · Deutsches Herzzentrum Muenchen

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196274 on ClinicalTrials.gov